Metsera (NASDAQ:MTSR) Shares Gap Up - Time to Buy?

Key Points

• Metsera Inc. (NASDAQ:MTSR) shares opened at $33.57, a gap up from the previous close of $32.39, but last traded at $30.25 with a trading volume of 402,169 shares.
• Analysts have bullish expectations for Metsera, with Guggenheim raising their price target from $56.00 to $62.00 and Wells Fargo setting a $65.00 target, while the consensus rating remains a "Buy" with an average target of $55.00.
• Despite recent analyst optimism, Metsera shares have declined by 9.2% and the company reported earnings of ($0.66) per share for the last quarter.

Metsera Inc. (NASDAQ:MTSR - Get Free Report)'s share price gapped up before the market opened on Tuesday . The stock had previously closed at $32.39, but opened at $33.57. Metsera shares last traded at $30.25, with a volume of 402,169 shares trading hands.

Analysts Set New Price Targets

MTSR has been the subject of a number of recent research reports. Guggenheim boosted their price target on Metsera from $56.00 to $62.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Wells Fargo & Company began coverage on Metsera in a research note on Friday, June 20th. They set an "overweight" rating and a $65.00 price target for the company. Five research analysts have rated the stock with a Buy rating, According to MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $55.00.

Metsera Stock Down 9.2%

The firm's 50-day moving average is $33.36.

Metsera (NASDAQ:MTSR - Get Free Report) last released its quarterly earnings results on Monday, July 28th. The company reported ($0.66) earnings per share for the quarter.

Institutional Investors Weigh In On Metsera

A number of institutional investors have recently added to or reduced their stakes in MTSR. BNP Paribas Financial Markets boosted its holdings in Metsera by 100.0% in the second quarter. BNP Paribas Financial Markets now owns 1,600 shares of the company's stock worth $46,000 after acquiring an additional 800 shares in the last quarter. Strs Ohio acquired a new stake in Metsera in the first quarter worth about $76,000. Virtus Investment Advisers LLC acquired a new stake in Metsera in the second quarter worth about $77,000. KLP Kapitalforvaltning AS acquired a new stake in Metsera in the second quarter worth about $122,000. Finally, Police & Firemen s Retirement System of New Jersey boosted its holdings in Metsera by 32.6% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 4,293 shares of the company's stock worth $122,000 after acquiring an additional 1,056 shares in the last quarter.

About Metsera

Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.